This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Sweta Killa
Sector ETF report for FSTA
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FTCS
Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $90.95 in the latest trading session, marking a -1.63% move from the prior day.
Colgate Stock Loses Ground: Can Strategies Aid a Turnaround?
by Zacks Equity Research
Colgate's (CL) grapples with soft sales and strained margins for quite a while now. Nevertheless, the company's cost-savings program appears promising.
Will P&G's (PG) Efforts Help Sustain Stock Momentum in 2019?
by Zacks Equity Research
Procter & Gamble (PG) displays momentum, backed by impressive growth strategies and cost-saving efforts to boost margins, which have boosted its top and bottom lines.
Dogs of the Dow Win in 2018: Will ETFs See Success in 2019?
by Sanghamitra Saha
Dogs of the Dow beat the broader market in 2018. Will Dogs ETFs be able to taste success this year too?
Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for FLQL
Procter & Gamble (PG) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Procter & Gamble (PG) have what it takes? Let's find out.
Procter & Gamble (PG) Stock Moves -0.71%: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $90.63, moving -0.71% from the previous trading session.
Factors Likely to Impact Helen of Troy's (HELE) Q3 Earnings
by Zacks Equity Research
Helen of Troy's (HELE) Q3 performance to gain from strong brands. However, dismal Beauty segment and commodity cost inflation are worries.
Constellation Brands (STZ) to Keep Earnings Beat Trend in Q3
by Zacks Equity Research
Constellation Brands' (STZ) strengthening beer business has been aiding its performance over the last several quarters. Additionally, brand building and product innovation efforts are key revenue drivers.
Buy 5 Dow Stocks to Strengthen Your Portfolio in 2019
by Nalak Das
The blue-chip index has been witnessing extreme volatility over the last three months.
The Zacks Analyst Blog Highlights: McCormick, Procter & Gamble, Church & Dwight, Ollie's Bargain Outlet and Lamb Weston
by Zacks Equity Research
The Zacks Analyst Blog Highlights: McCormick, Procter & Gamble, Church & Dwight, Ollie's Bargain Outlet and Lamb Weston
Why P&G (PG) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
P&G (PG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: Procter & Gamble, Oracle, United Parcel Service, FedEx and AstraZeneca
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, Oracle, United Parcel Service, FedEx and AstraZeneca
5 Consumer Staples Stocks That Escaped 2018 Sector Shortfall
by Vrishali Bagree
Despite the barriers in the consumer staples sector, there are some companies that look promising on the back of solid pricing initiatives, focus on innovation and diversification.
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for FTCS
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
Top Research Reports for Procter & Gamble, Oracle & United Parcel Service
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Oracle (ORCL) and United Parcel Service (UPS).
Procter & Gamble (PG) Stock Moves -0.85%: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $90.98, moving -0.85% from the previous trading session.
Clorox's (CLX) 2020 Strategy on Track, Margin Woes Linger
by Zacks Equity Research
Clorox (CLX) benefits from 2020 strategy, expansion of e-commerce capabilities and brand management initiatives. However, dismal margins and soft fiscal earnings view are concerns.
4 Stocks to Gain From Fed's Not-So-Dovish Stance for 2019
by Zacks Equity Research
Although a December rate hike was expected, Fed's plans for 2019 doesn't make investors happy.
Can Coty's Solid Strategies Help the Stock Revive in 2019?
by Zacks Equity Research
Coty (COTY) is struggling with softness in its Consumer Beauty segment and supply-chain disruptions. Nonetheless, the company's Luxury and Professional Beauty segments are performing well.
Why Procter & Gamble (PG) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Procter & Gamble (PG) have what it takes? Let's find out.
Procter & Gamble (PG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $96.64, marking a +0.16% move from the previous day.